Inter-observer Reproductibility of Visual Estimation of Left Ventricular Ejection Fraction in Critical Care

Sponsor
University Hospital, Montpellier (Other)
Overall Status
Completed
CT.gov ID
NCT04978389
Collaborator
(none)
10
1
3.6
2.8

Study Details

Study Description

Brief Summary

Inter-observer reproductibility of visual estimation of left ventricular ejection fraction is known to be good in cardiology but has not been studied in ICU. The goal of the study is to determine if this reproductibility is good enough.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    10 participants
    Observational Model:
    Other
    Time Perspective:
    Other
    Official Title:
    Inter-observer Reproductibility of Visual Estimation of Left Ventricular Ejection Fraction in Critical Care
    Actual Study Start Date :
    Sep 1, 2021
    Actual Primary Completion Date :
    Dec 1, 2021
    Actual Study Completion Date :
    Dec 20, 2021

    Outcome Measures

    Primary Outcome Measures

    1. reproductibility of LVEF in percentage [day 1]

      reproductibility of LVEF in percentage

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion criteria:
    • practitioners working in intensive care.

    • age > 18 years

    Exclusion criteria:
    • Age under 18

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Uhmontpellier Montpellier France 34295

    Sponsors and Collaborators

    • University Hospital, Montpellier

    Investigators

    • Study Director: Kada KLOUCHE, MD PhD, UH Montpellier

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Montpellier
    ClinicalTrials.gov Identifier:
    NCT04978389
    Other Study ID Numbers:
    • RECHMPL21_0462
    First Posted:
    Jul 27, 2021
    Last Update Posted:
    Feb 2, 2022
    Last Verified:
    Jan 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Feb 2, 2022